MEDP - Medpace Profit before interest, taxes and amortization

Graphic logo of Medpace (MEDP)

Can August Trokenbrodt's strong team ensure margin leadership for Medpace Holdings, Inc. (MEDP)? The answer lies in the CRO organization's diversified trial portfolio, which mitigates project risks. Operating cash flow before interest and taxes confirms this success, where the 638.28 level represents the current figure. The rise in share price now relies on the "all-in-one" model and the influx of investment into small-cap biotech.

Operating profit before deduction of amortization: Medpace Holdings (MEDP) for 11/23/2025 - 11/15/2026

Summary analytical data breakdowns for Medpace Corp (MEDP)

- current price and projected stock value:
Price Medpace Holdings, Inc.|MEDP - Analyst Consensus Forecast
- market capitalization statistics:
Market Value Medpace Holdings, Inc.|MEDP - Total Company Value
- book capitalization data:
Net Assets per Share Medpace|MEDP - Company Net Assets|Market Cap to Book Value Multiple medpace.com|MEDP - Aggregate Company Assets
- debt level and financial liquidity data:
Total Debt to Capital Coefficient Medpace Holdings, Inc.|MEDP - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Medpace Inc.|MEDP - Company Aggregate Debts|Debts to Book Value Medpace Holdings|MEDP - Company Long-Term Debts|Company Short-Term Indebtedness Medpace|Critical Liquidity Ratio medpace.com
- company profitability and valuation multiples indicators:
MEDP - Net Profit|Projected Future Earnings Medpace Holdings, Inc.|MEDP - P/E Multiple|Projected Price to Earnings Medpace|MEDP - PEG Multiple|Company Value to EBITDA Medpace Inc.|MEDP - Operating profit before deduction of amortization|Earnings per share for the trailing year Medpace|MEDP - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months medpace.com|MEDP - Earnings per share growth in current year|Expected net earnings per share growth next year Medpace Holdings, Inc.
- sales and revenue indicators:
MEDP - Company Revenue|Company Projected Revenue Medpace Holdings, Inc.|MEDP - P/S Multiple|Market Cap to Projected Revenue Medpace Holdings|MEDP - Sales Growth YoY (TTM)
Summary company analytics:Medpace Holdings, Inc.
Signature product of Medpace Inc.

Medpace Holdings, Inc. (MEDP) long-term clinical trial contracts drive the dynamics of absolute EBITDA. This indicator measures real cash flow from core operations, excluding the impact of debt load and accounting write-offs. It captures actual cash generation, stripped of non-cash expenses. Sharp spikes in values often signal one-time payments rather than systemic growth. It is critical for investors to avoid purchasing the asset at the peaks of this metric to prevent capital freeze.

Who Medpace Holdings, Inc. competes with

iqvia.com (IQV) - Profit before interest, taxes and amortization|LH: Operating profit before deduction of amortization|Profit before interest, taxes and amortization ICON Corp|CRL (Charles River) - Operating profit before deduction of amortization|EVO: Company profit before taxes, interest and amortization|Operating profit before deduction of amortization FTRE|LFCR (lifecore.com) - Company profit before taxes, interest and amortization|Profit before payment of interest, taxes and amortization OmniAb Inc. (OABI)|Operating income before deduction of amortization Inotiv|Operating profit EBITDA CDMO (Avid Bioservices Inc.)|CTLT - Operating profit before deduction of amortization|nighthawkbio.com - Operating profit EBITDA